Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
| العنوان: | Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) |
|---|---|
| المؤلفون: | Xiao Chen, Linda Carlin, Nidhi Jain, V Bernard, Kathleen L. Irwin, Daniel E. Montaño, Mona Saraiya |
| المصدر: | Cancer. 110:1024-1032 |
| بيانات النشر: | Wiley, 2007. |
| سنة النشر: | 2007 |
| مصطلحات موضوعية: | Adult, Male, Oncology, Program evaluation, Cancer Research, medicine.medical_specialty, Cytodiagnosis, Psychological intervention, Uterine Cervical Neoplasms, Cervical cancer screening, Breast cancer, Internal medicine, medicine, Humans, Mass Screening, Practice Patterns, Physicians', Management practices, Reimbursement, Vaginal Smears, Colposcopy, Cervical cancer, Gynecology, Primary Health Care, medicine.diagnostic_test, Obstetrics, business.industry, Obstetrics and Gynecology, General Medicine, Middle Aged, medicine.disease, United States, Women's Health Services, Early Diagnosis, Cervical cancer early detection, Liquid-based cytology, Family medicine, Practice Guidelines as Topic, Female, business, Medicaid, Papanicolaou Test, Program Evaluation |
| الوصف: | BACKGROUND. This study was conducted to describe clinicians serving women in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) with regard to demographic and practice characteristics and their usual practices in cervical cancer screening and abnormal cytology management, as well as human papillomavirus (HPV) test use. METHODS. The authors analyzed data from a nationally representative survey conducted in 2004 of providers practicing 7 specialties that commonly offer cervical cancer screening. The program providers were compared with nonprogram providers. RESULTS. Program providers were found to be significantly more likely than nonprogram providers to be midlevel providers and to serve low-income, racial/ethnic minorities who are insured by Medicaid. In addition, they had significantly more patients with abnormal Papanicolaou tests and were more likely to offer onsite colposcopy (57% vs 40%). Program providers were less likely to use liquid-based cytology (LBC) as their sole method for cytology. Approximately 20% of program and nonprogram providers used HPV DNA testing as an adjunct to screening cytology and two-thirds used HPV tests to manage patients with abnormal cytology results. However, many also used HPV testing for reasons not approved by the U.S. Food and Drug Administration (FDA), such as for screening women age |
| تدمد: | 1097-0142 0008-543X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19fd87551382450e486a4a47887ca91aTest https://doi.org/10.1002/cncr.22875Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....19fd87551382450e486a4a47887ca91a |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 10970142 0008543X |
|---|